Griffith University is proud to announce Professor Paul Clarke will join the University as the inaugural Executive Director of the new Institute for Biomedicine and Glycomics and the Raymond James Chair of Translational Biomedicine.
In the new executive leadership role, Professor Clarke will work alongside colleagues who are dedicated to the development of novel therapies, vaccines and diagnostics for diseases of global impact, and the translation of world-leading biomedical research to improve human health.
Professor Clarke brings an enormous depth of experience to the role as both a leader and internationally recognised biomedical researcher who has worked at the translational interface between medicine and biology for more than 25 years.
Professor Clarke’s area of discipline focuses on investigating cancer cell biology and cellular responses to anti-cancer drugs.
“I am delighted to be joining Griffith to lead the Institute for Biomedicine and Glycomics and integrate the outstanding biomedical research capabilities at the University,” Professor Clarke said.
“This is an exciting time for biomedicine in South East Queensland and I believe there will be outstanding opportunities to build our connections with healthcare and industry to deliver real improvements in people’s lives.”
He has received a prestigious Royal Society Wolfson Research Merit Award, Research Fellowships from The Wellcome Trust and Cancer Research UK, and is a Fellow of the Royal Society of Biology.
Professor Clarke comes to Griffith from the University of Queensland where he is the Director of the Frazer Institute which he has led to significant success since 2017.
Prior to that, he held leadership roles in the School of Medicine at the University of Dundee, Scotland.
Deputy Vice Chancellor (Research) Professor Lee Smith said Professor Clarke’s wealth of experience aligns strongly to the strategic vision and goals of Griffith’s new flagship Institute for Biomedicine and Glycomics.
“His leadership experience in Australia and the United Kingdom will allow him to play a key role in fostering a high-performing and collaborative research environment which integrates Institute members from across the University to leverage Griffith’s significant breadth, depth and excellence in discovery and translational biomedical research,” Professor Smith said.
“We welcome the opportunity to build on our proud history of research excellence and translational successes.
“We look forward to forging a transformative new chapter for biomedical research at Griffith University under the leadership of Professor Paul Clarke.”
Professor Clarke will join Griffith University on 4 November, 2024.
